Researchers at the University of Calgary are launching an unconventional study that asks Canadians to donate their toenail clippings — up to 10,000 samples — to investigate how radon exposure contributes to lung cancer. The initiative aims to develop a precise method for measuring radon levels in the body and correlate that data with cancer risk, potentially leading to earlier detection and improved survival rates.
Radon, a naturally occurring radioactive gas, is the second leading cause of lung cancer after smoking, according to health authorities. It seeps into homes from soil and can accumulate to dangerous levels without detection. Current methods for estimating radon exposure rely on home testing kits or retrospective questionnaires, which can be imprecise. The University of Calgary team believes toenails may offer a more reliable biomarker because they absorb radon over time, providing a cumulative record of exposure.
“Toenails grow slowly and incorporate elements from the environment, making them ideal for long-term exposure assessment,” the researchers stated in their announcement. Participants will be asked to mail in clippings along with basic health information. The samples will be analyzed for radon decay products, and the data will be cross-referenced with participants’ residential history and lung cancer incidence.
Early diagnosis of lung cancer is critical for effective treatment, and understanding individual radon exposure could help identify high-risk populations. Companies like Calidi Biotherapeutics Inc. (NYSE American: CLDI) are advancing cancer therapies, but prevention and early detection remain key. The study’s findings could inform public health policies and encourage more widespread radon testing and mitigation.
The call for toenail donations is part of a broader trend in citizen science, where ordinary people contribute to research in unconventional ways. The researchers emphasize that the process is simple and non-invasive, and all personal data will be kept confidential. They hope to collect samples from diverse geographic regions across Canada to capture varying radon levels.
For more information on the study, visit the BioMedWire platform, which covers developments in biotechnology and life sciences. BioMedWire is a specialized communications platform focusing on the latest in biotech and biomedical sectors, and is part of the Dynamic Brand Portfolio @IBN that provides a range of corporate communications solutions.
